
Britain’s competition regulator announced on Wednesday, June 23, that it has received commitments from housebuilder Persimmon and insurer Aviva as part of a long-running investigation into possible mis-selling of leasehold homes and high ground rents.
The Competition and Markets Authority (CMA) stated Aviva will remove unfair ground rent terms and repay owners whose rents were doubled, while Persimmon will offer leasehold owners an option to get complete ownership of the property at lower rates.
The regulator launched the probe in September last year, with cases against Barratt Developments, Persimmon, Taylor Wimpey, and Countryside Properties.
CMA in March asked Taylor Wimpey and Countryside to drop the unfair rent terms. Both companies then stated they would cooperate with the regulator.
CMA announced on Wednesday it was also investigating several investment firms which bought freeholds from two developers and used the same terms, adding that Persimmon also agreed to extend the time during which buyers can exchange contracts after reserving a property.
Persimmon stated the undertakings with the regulator formally end the probe into the company, while Aviva stated one of its funds had agreed to amend terms for around 1,000 leases it had acquired.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas